1. WHO. Antimicrobial resistance: global report on surveillance 2014. Geneva: World Health Organization; 2014. Available from:
https://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf?sequence=1
. Accessed 20 Feb 2019.
2. Xie YL, Chakravorty S, Armstrong DT, Hall SL, Via LE, Song T, et al. Evaluation of a rapid molecular drug-susceptibility test for Tuberculosis. N Engl J Med. 2017;377(11):1043–54.
3. WHO. Global Tuberculosis Report. 2018. Geneva: World Health Organization; 2018. Available from:
https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf
. Accessed 20 Feb 2019.
4. European Centre for Disease Prevention and Control & WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2019 – 2017 data. Copenhagen: European Centre for Disease Prevention and Control; 2019. Available from:
https://ecdc.europa.eu/sites/portal/files/documents/tuberculosis-surveillance-monitoring-Europe-2019-20_Mar_2019.pdf
. Accessed 20 Feb 2019.
5. DGS. Programa Nacional para a Infeção VIH, Sida e Tuberculose 2017. Lisboa. Available from: file:///C:/Users/Utilizador/Downloads/DGS_PNSida2017_V12.pdf, Direção-Geral da Saúde. Accessed 20 Feb 2019.